Prevention of premature labor by 17 alpha-hydroxyprogesterone caproate

Yemini M; Borenstein R; Dreazen E; Apelman Z; Mogilner BM; Kessler I; Lancet M

doi:10.1016/0002-9378(85)90141-3

Pregnancy Preterm Birth

Prevention of premature labor by 17 alpha-hydroxyprogesterone caproate

Yemini M, Borenstein R, Dreazen E, Apelman Z, Mogilner BM, Kessler I, Lancet M

Published March 1985 American Journal of Obstetrics and Gynecology, 151(5), 574-577

DOI 10.1016/0002-9378(85)90141-3 PMID 3976757

Abstract

Eighty pregnant women at high risk of giving birth prematurely were divided randomly into two groups. Treatment with either 17 alpha-hydroxyprogesterone caproate, 250 mg by intramuscular injection once a week, or a placebo was given in a double-blind fashion. Imminent premature labor occurred in 29.0% of the treated group and in 59.4% of the control group (p less than 0.025). The rate of premature deliveries was also significantly lower in the treated group (16.1%) than in the control group (37.82%) (p less than 0.05). There were no cases of perinatal death or fetal malformations in either group. The mean birth weight of all infants of the treated group was significantly higher than in those of the control group (3111.9 +/- 905 gm versus 2680 +/- 813.4 gm, p less than 0.05). The results support treatment with progesterone caproate for the prevention of premature labor.

Topics

Pregnancy › Preterm Birth › Progesterone Prophylaxis · Birth and Delivery › Labor and Birth › Physiologic Birth · Therapeutics › Hormonal Agents › Progesterone and Progestins

PMID 3976757 3976757 DOI 10.1016/0002-9378(85)90141-3 10.1016/0002-9378(85)90141-3 Yemini et al. 1985, Yemini 1985

Keywords

17-alpha-Hydroxyprogesterone, Adult, Birth Weight, Double-Blind Method, Female, Humans, Hydroxyprogesterones/therapeutic Use, Infant Mortality, Infant, Newborn, Infant, Premature, Obstetric Labor, Premature/prevention & Control, Pregnancy, Random Allocation, Hydroxyprogesterones, 17-alpha-Hydroxyprogesterone

Prevention of premature labor by 17 alpha-hydroxyprogesterone caproate

Abstract

Topics

By this author

Tamoxifen treatment in women with failure of clomiphene citrate therapy

Teratogenicity of progestogens given during the first trimester of pregnancy

Treatment of premature labor contractions with combined ritodrine and indomethacine

Related research

Efficacy of 17alpha-hydroxyprogesterone caproate in the prevention of premature labor

Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate

Progestogen administration in pregnancy may prevent preterm delivery

A chronicle of the 17-alpha hydroxyprogesterone caproate story to prevent recurrent preterm birth

Keywords